Michael Messinger
Director/Miembro de la Junta en FILAMENT HEALTH CORP. .
Fortuna: - $ al 31/05/2024
Perfil
Michael Messinger's current job is as a Director at Filament Health Corp.
His former jobs include being a Finance Director at Lexicon Pharmaceuticals, Inc., an Auditor at Ernst & Young LLP, and a Controller at Coelacanth Corp.
He also served as the President, Chief Executive & Operating Officer at ContraFect Corp.
Mr. Messinger obtained his undergraduate degree from the University of Michigan.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CONTRAFECT CORP.
0.00% | 06/09/2023 | 23 ( 0.00% ) | 0 $ | 31/05/2024 |
Cargos activos de Michael Messinger
| Empresas | Cargo | Inicio |
|---|---|---|
| FILAMENT HEALTH CORP. | Director/Miembro de la Junta | 28/03/2024 |
Antiguos cargos conocidos de Michael Messinger.
| Empresas | Cargo | Fin |
|---|---|---|
| CONTRAFECT CORPORATION | Director Ejecutivo | 04/12/2023 |
| LEXICON PHARMACEUTICALS, INC. | Director Financiero/CFO | 01/01/2012 |
Coelacanth Corp.
 Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Coelacanth Corp. is a company that researches drug development. The company is based in East Windsor, NJ. The company was founded by Robert Grubbs. Coelacanth was acquired by Lexicon Pharmaceuticals, Inc. on 2001-07-12 for $31.9 million. | Comptroller/Controller/Auditor | 01/01/2001 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01/01/1999 |
Formación de Michael Messinger.
| University of Michigan | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| CONTRAFECT CORPORATION | Health Technology |
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| FILAMENT HEALTH CORP. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Coelacanth Corp.
Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Coelacanth Corp. is a company that researches drug development. The company is based in East Windsor, NJ. The company was founded by Robert Grubbs. Coelacanth was acquired by Lexicon Pharmaceuticals, Inc. on 2001-07-12 for $31.9 million. | Commercial Services |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
- Bolsa de valores
- Insiders
- Michael Messinger
